RNA, U6atac small nuclear 17, pseudogene (RNU6ATAC17P)

RNU6ATAC17P refers to a processed pseudogene derived from U6atac small nuclear RNA, which is part of the splicing machinery in eukaryotic cells[3][5]. Unlike canonical U6atac snRNA, which is transcribed by RNA Polymerase III and is integrated into the minor spliceosome, the pseudogene does not produce a functional RNA product and is classified as a noncoding genetic element. Pseudogenes like RNU6ATAC17P are typically the result of retrotransposition events mediated by LINE-1 (L1) elements, which can mobilize snRNA sequences in the genome. These pseudogenes are characterized by the absence of introns, scattered base mismatches, and sometimes a poly(A) tail, but they are transcriptionally inactive and do not contribute to splicing or other cellular functions[3]. There is no evidence of direct involvement in human disease, drug interaction, or use as a clinical biomarker. Their primary importance is as molecular markers in genome evolution and retrotransposon activity, not as pharmacological or therapeutic targets[3][5].

Other names

RNU6ATAC17PU6atac pseudogene 17RNA U6atac snRNA pseudogene 17